GlassScriptPhysician profile
Ankit R Desai
NPI 1932302387
$13,121.67
in general payments reported to CMS, 2019-2025
36 companies · $3,366 in 2025
The $3,366 reported for 2025 was more than what 89% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $151 · 2021: $829 · 2022: $6,441 · 2023: $987 · 2024: $926 · 2025: $3,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,343 · Travel and Lodging: $1,765 · Grant: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,342.99 |
| Travel and Lodging | $1,764.70 |
| Grant | $171.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Innovation Associates, INC. | $3,822.33 | 2022 | |
| Mentor Worldwide LLC | $2,493.39 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Axogen | $2,111.66 | 2021-2025 | |
| Musculoskeletal Transplant Foundation INC. | $1,211.95 | 2021-2025 | |
| Abbvie INC. | $1,149.02 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox, Strattice Reconstructive Tissue Matrix Bps |
| Allergan, INC. | $514.48 | 2019-2022 | |
| Tela Bio, INC. | $223.37 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sientra, INC. | $219.03 | 2021-2022 | |
| Ethicon INC. | $147.05 | 2025 | Dermabond, Stratafix |
| Merz North America, INC. | $135.45 | 2021 | |
| Kerecis Limited | $120.13 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Motiva USA, LLC | $103.85 | 2025 | |
| Next Science LLC | $103.01 | 2021 | |
| Progenacare Global, LLC | $98.66 | 2023 | |
| Integra Lifesciences Corporation | $72.72 | 2022-2023 | Durasorb Monofilament Mesh |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $61.98 | 2020-2025 | Stravix, Grafix Pl |
| Axonics, INC. | $57.24 | 2022-2023 | Bulkamid |
| Kci USA, INC. | $49.93 | 2019-2023 | Prevena, Activ.A.C., Promogran Prisma |
| Stryker Corporation | $48.72 | 2021-2022 | |
| Acell, INC. | $43.24 | 2019 | |
| Innovation Technologies INC | $37.61 | 2020-2022 | |
| Medela LLC | $30.23 | 2020 | |
| Galderma Laboratories, L.P. | $27.80 | 2020-2021 | |
| Ethicon US, LLC | $26.89 | 2020-2022 | |
| Coopersurgical, INC. | $25.69 | 2022 | |
| Biotissue Holdings INC. | $24.33 | 2023 | |
| Acera Surgical, INC. | $22.72 | 2022 | |
| Convatec INC. | $20.03 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.05 | 2020 | |
| Solventum Corporation | $17.81 | 2025 | V.A.C. Veraflo, Prevena, Activ.A.C. |
| Vertex Pharmaceuticals Incorporated | $17.68 | 2025 | |
| Misonix INC | $16.38 | 2020 | |
| Revance Therapeutics, INC. | $15.83 | 2024 | Daxxify |
| Solta Medical, A Division of Bausch Health US, LLC | $13.77 | 2020 | |
| Bioventus LLC | $12.09 | 2022 | |
| Reprise Biomedical, INC. | $7.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.